Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders
Open accessThe DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Expansion of G4C2 repeats within the C9ORF72 gene is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Such repeats lead to decreased expression of the autophagy regulator C9ORF72 protein. Furthermore, sense and antisense repeats are translated into toxic dipeptide repeat (DPR) proteins. It is unclear how these repeats are translated, and in which way their translation and the reduced expression of C9ORF72 modulate repeat toxicity. Here, we found that sense and antisense repeats are translated upon initiation at canonical AUG or near‐cognate start codons, resulting in polyGA‐, polyPG‐, and to a lesser degree polyGR‐DPR proteins. However, accumulation of these proteins is prevented by autophagy. Importantly, reduced C9ORF72 levels lead to suboptimal autophagy, thereby impairing clearance of DPR proteins and causing their toxic accumulation, ultimately resulting in neuronal cell death. Of clinical importance, pharmacological compounds activating autophagy can prevent neuronal cell death caused by DPR proteins accumulation. These results suggest the existence of a double‐hit pathogenic mechanism in ALS/FTD, whereby reduced expression of C9ORF72 synergizes with DPR protein accumulation and toxicity. An expansion of G4C2 repeats in the C9ORF72 gene causes amyotrophic lateral sclerosis (ALS). Here, cell transfection and mass spectrometry indicate that G4C2 repeats are translated through classical initiation to cognate ATG or near‐cognate start codons. Furthermore, impaired autophagy due to reduced expression of the C9ORF72 protein synergizes toxicity of G4C2 translation. ALS‐linked sense and antisense repeats are translated into toxic peptides that require clearance by C9ORF72‐dependent autophagy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Intriguingly, these two mechanisms may synergize in disease7.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the loss of C9orf72 function and consequent impairment in autophagy may enhance DPR accumulation in C9orf72 mutation carriers, acting synergistically to accentuate neurodegeneration [154,172,173].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“ALS patients can present significant clinical, genetic, and histopathological overlaps with frontotemporal dementia (FTD), a presenile dementia affecting frontal and temporal brain regions (Lomen-Hoerth et al , 2002; Ringholz et al , 2005; Neumann et al , 2006).”
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 3×
“…expansion of GGGGCC (G4C2) repeats within the first intron of the C9ORF72 gene as the most common inherited cause for both ALS and FTD in Caucasian populations of northern Europe and North America (DeJesus-Hernandez et al , 2011; Renton et al , 2011; Gijselinck et al , 2012; Majounie et al , 2012).”
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · cited 1×
“…expansion of GGGGCC (G4C2) repeats within the first intron of the C9ORF72 gene as the most common inherited cause for both ALS and FTD in Caucasian populations of northern Europe and North America (DeJesus-Hernandez et al , 2011; Renton et al , 2011; Gijselinck et al , 2012; Majounie et al , 2012).”
Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187 · cited 2×
“…form inclusions throughout the brain of patients with C9-ALS/FTD (Ash et al , 2013; Gendron et al , 2013; Mori et al , 2013; Zu et al , 2013), as well as in mice expressing expanded G4C2 repeats (Chew et al , 2015; O’Rourke et al , 2015; Peters et al , 2015; Jiang et al , 2016; Liu et al , 2016).”
Autophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210 · cited 1×
“…expansion of GGGGCC (G4C2) repeats within the first intron of the C9ORF72 gene as the most common inherited cause for both ALS and FTD in Caucasian populations of northern Europe and North America (DeJesus-Hernandez et al , 2011; Renton et al , 2011; Gijselinck et al , 2012; Majounie et al , 2012).”
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982 · cited 1×
“…2017; Lopez-Gonzalez et al , 2019), nuclear and nucleolar organization (White et al , 2019; Zhang et al , 2019), and/or nucleocytoplasmic transport (Kwon et al , 2014; May et al , 2014; Mizielinska et al , 2014; Wen et al , 2014; Zhang et al , 2015, 2016; Freibaum et al , 2015; Jovi (cid:1) ci (cid”
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978 · cited 1×
“…foci that recruit various RNA-binding proteins, potentially altering their localization and functions (Almeida et al , 2013; Donnelly et al , 2013; Lagier-Tourenne et al , 2013; Lee et al , 2013; Mizielinska et al , 2013; Cooper-Knock et al , 2014; Haeusler et al , 2014; Conlon et al , 2016, 2018).”
Cited by
Items 101–147 of 147
Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models
Seidel, M., Rajkumar, S., Steffke, C., Noeth, V., Agarwal, S., Roger, K., Lipecka, J., Ludolph, A. C., Guerrera, I. C., Boeckers, T. M., et al. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100105 · Cited by 6
Ma, L., Chen, L., Wang, J., Chang, Q., Wang, Y., Zhang, W., Du, Y., Sadan, J., & Chen, J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac271 · Cited by 5
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity
Morón-Oset, J., Fischer, L. K., Jauré, N., Zhang, P., Jahn, A. J., Supèr, T., Pahl, A., Isaacs, A. M., Grönke, S., & Partridge, L. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01634-6 · Cited by 5
Steffke, C., Agarwal, S., Kabashi, E., & Catanese, A. (2024) · Cells · doi:10.3390/cells13151300 · Cited by 5
Role of lysosomal morphology in aging and age-related diseases
Liu, H., Tang, H., & Pang, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103033 · Cited by 4
Xu, X., Li, M., Su, Y., Wang, Q., Qin, P., Huang, H., Zhang, Y., Zhou, Y., & Yan, J. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14319 · Cited by 4
RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD
Webster, C. P., Hall, B., Crossley, O. M., Dauletalina, D., King, M., Lin, Y.-H., Castelli, L. M., Yang, Z.-L., Coldicott, I., Kyrgiou-Balli, E., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402757 · Cited by 4
Alberti, C., Parente, V., Corti, S. P., & Sansone, V. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107192 · Cited by 3
Nemo-like kinase disrupts nuclear import and drives TDP43 mislocalization in ALS
Bekier, M. E., Pinarbasi, E., Krishnan, G., Mesojedec, J. J., Hurley, M., Harikumar Sheela, H., Collins, C. A., Ghaffari, L., de Majo, M., Ullian, E. M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188138 · Cited by 2
The C9orf72/SMCR8 complex maintains microglial homeostasis via RAB8A-ESCRT-mediated lysosomal repair
Li, S., Xu, S., Li, F., Zhao, Q., Zhang, P., Guan, Q., Sun, X., Bi, J., Xiao, H., Tang, Y., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00817-w · Cited by 2
Lysosomal dysfunction in neurodegenerative disease
Brooker, S. M., Coukos, R., & Krainc, D. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01262-3 · Cited by 2
Vourc’h, P., Wurmser, F., Brulard, C., Mouzat, K., Kassem, S. B., Dangoumau, A., Laumonnier, F., Blasco, H., Corcia, P., & Andres, C. R. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.027 · Cited by 2
Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides
Marzullo, M., Simone, A. D., Terribili, M., Salvio, M. D., Mengistu, D. Y., Somma, M. P., D'Amico, R., Canettieri, G., Cestra, G., & Ciapponi, L. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052729 · Cited by 1
Flight to insight: maximizing the potential of Drosophila models of C9orf72-FTD
d’Almeida, N. A., & Tipping, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1434443 · Cited by 1
Uyan, Ö., Sambare, S., Oomen, M. E., Wightman, N., Schooley, A., Klim, J. R., Belaghzal, H., Aydemir, Ö., Oksuz, B. A., USLU, Z. S. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.22.677835 · Cited by 1
A Chemical Inducer of Ribophagy Limits the Toxicity of ALS-Related Arginine-Rich PeptidesPreprint
Porębski, B., Lafarga, V., Hansel, C. S., Haraldsson, M., Sáez-Mas, A., Sánchez-Molleda, Á., Moragón, S., Häggblad, M., Lidemalm, L., Rodrigo, S., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7284617 · Cited by 1
Comprendre et modéliser la Sclérose Latérale Amyotrophique à début précoce
Muratet, F. (2022) · theses.fr (ABES) · doi:10.70675/9a7778aaz88c7z40b1z92d3zaf5699b86a09 · Cited by 1
Structural and functional characterization of the lysosomal amino acid transporter PQLC2
Jamal, L. (2024) · theses.fr (ABES) · doi:10.70675/657f2ba1z9911z43bbza9c9zd6f6ab1aba13 · Cited by 1
Kaivola, K. (2020) · Helda - University of Helsinki Institutional Repository
Green, K. (2020) · Deep Blue (University of Michigan)
Sonobe, Y., Lee, S., Krishnan, G., Gu, Y., Kwon, D. Y., Gao, F., Roos, R. P., & Kratsios, P. (2023) · eLife · doi:10.7554/elife.83189.sa2
Boivin, M. (2022) · theses.fr (ABES) · doi:10.70675/e34bd433z5d16z4915z9f83zbb0f4c84087b
Self-citationGu, Y., Kankel, M. W., Watts, J. K., Jafar‐Nejad, P., & Almeida, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.04.616663
Pena, C. (2024) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2024.29
Ito, L., & Galipon, J. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.24-00209-3
Advanced Delivery Systems and Gene Editing in Neurotherapeutics
Upadhyay, P., Suhail, A., & Kumar, S. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_15
Quezada, E. R., Cappelli, C., Díaz, I. D. P., Jury, N., Wightman, N., Brown, R. H., Montecino, M. A., & van Zundert, B. (2021) · Figshare · doi:10.6084/m9.figshare.14227789
Quaegebeur, A., Glaria, I., Lashley, T., & Isaacs, A. M. (2020) · Figshare · doi:10.6084/m9.figshare.13212128
Coneys, R. (2024) · UCL Discovery (University College London)
Understanding Mitochondrial Dysfunction Linked to C9orf72 Hexanucleotide Repeat Expansion
Anoar, S. (2025) · UCL Discovery (University College London)
Wild-type C9orf72 expression is a genetic modifier of C9-ALS survivalPreprint
Tsitkov, S., Raju, A., Wu, J., Li, J., Lim, R. G., Wu, Z., Bistami, N. A., Eyk, J. E. V., Svendsen, C. N., Rothstein, J. D., et al. (2026) · medRxiv · doi:10.64898/2026.02.06.26345684
Baral, A., Bilal, M., Dai, H., Jun, Y., Almeida, S., Gao, F., & Yao, W.-D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.24.707507
Investigating the Effects of C9orf72 Haploinsufficiency on TDP-43 Pathology in ALS
Lin, L. T. W. (2023) · TSpace (University of Toronto)
Effect of G 4 C 2 repeat expansions on the motion of lysosomes inside neurites
Mytiliniou, M., Wondergem, J. A. J., Feliksik, M., Schmidt, T., Fuhs, T., & Heinrich, D. (2026) · Physical Biology · doi:10.1088/1478-3975/ae5143
Picard, F. (2024) · theses.fr (ABES) · doi:10.70675/4a7f60caz630dz45d7z869fzc4b0454fc792
Mori, K., Gotoh, S., Kondo, S., Fujino, Y., Uozumi, R., Miura, K., 青木由樹, Tagami, S., Akamine, S., Miyamoto, T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.08.717149
Russell, K. A., Shahrabi, A. A., Akerman, S. C., Byrne, M. D., Rothstein, J. D., Trotti, D., Jensen, B. K., & Haeusler, A. R. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02341-8
Chromosome 9 Open Reading Frame 72 as a Multifunctional Regulator of Cellular Homeostasis
Chan, S. C., Yang, S., Wu, P., Chen, S.-F., Cheng, P., & Tung, C.-W. (2026) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-26-00014
Investigating the Role of C9orf72 in Synaptic Function
Gebregergis, B. T. (2026) · TSpace (University of Toronto)
Suri, P., Daartey, A. B., Khan, D. M. I. O., Rayana, N. P., Chilamakuri, R., Godugu, D., Azad, M. G., Reeb, K. L., & Richardson, D. R. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100158
Almeida, S., Gu, Y., & Kankel, M. W. (2026) · Cells · doi:10.3390/cells15181701
Smeele, P. H., Ferrari, V., Spina, G., Doná, E., Cauchi, R., Poletti, A., & Vaccari, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.09.765393
Bauer, C. S., Webster, C. P., Shaw, A. C., Kok, J. R., Castelli, L. M., Lin, Y.-H., Smith, E. F., Illanes-Álvarez, F., Higginbottom, A., Shaw, P. J., et al. (2022) · doi:10.3389/fncel.2022.1061559.s001
Metadata
- Authors
- Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Sellier, Chantal
- Charlet‐Berguerand, Nicolas
- Venue
- The EMBO Journal
- Published
- 2020-01-13
- Volume
- 39
- Issue
- 4
- Pages
- e100574-e100574
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7024836
- OpenAlex
- W2999593520
- Cited by
- 137
- References
- 106
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 19 · 2023: 30 · 2022: 14 · 2021: 29 · 2020: 17
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Funders
- Agence Nationale de la Recherche (ANR‐10‐LABX‐0030‐INRT, ANR‐10‐IDEX‐0002‐02)
- European Research Council (ERC‐2012‐StG #310659)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- C9orf72, G4C2 repeat expansion, dipeptide repeat proteins, autophagy, amyotrophic lateral sclerosis, frontotemporal dementia, neuronal cell death, autophagy activators
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Autophagy, Dipeptides, Humans, Neurons, Proteins, Cell Death, DNA Repeat Expansion, Frontotemporal Dementia, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.